id: NEW:cannabinoid_use_for_chronic_pain_to_chronic_pain
name: Cannabinoid Use for Chronic Pain â†’ Chronic Pain Severity
from_node:
  node_id: NEW:cannabinoid_use_for_chronic_pain
  node_name: Cannabinoid Use for Chronic Pain
to_node:
  node_id: chronic_pain
  node_name: Chronic Pain Severity
direction: negative
category: behavioral
mechanism_pathway:
- 'Step 1: Cannabinoids (THC and CBD) are administered via various routes (oral, sublingual,
  topical, inhaled) to patients with chronic pain conditions'
- 'Step 2: Cannabinoids interact with the endocannabinoid system, modulating pain
  signaling pathways, particularly effective in neuropathic pain conditions'
- 'Step 3: THC-containing products (comparable THC-to-CBD ratio ~1:1 and synthetic
  high-THC products) produce small improvements in pain severity'
- 'Step 4: CBD provides additional benefits through its non-intoxicating analgesic
  and anti-inflammatory properties with minimal adverse effects'
- 'Step 5: Some patients successfully substitute cannabinoids for other pain medications
  including opioids, reducing overall pain medication burden'
evidence:
  quality_rating: B
  n_studies: 4
  primary_citation: 'K. Boehnke and D. Clauw 2022. Cannabinoids for Chronic Pain:
    Translating Systematic Review Findings Into Clinical Action. Annals of Internal
    Medicine.'
  supporting_citations:
  - McDonagh and colleagues (1) - systematic review of placebo-controlled trials and
    cohort studies referenced in the primary paper
description: Cannabinoid use for chronic pain is associated with small improvements
  in pain severity, primarily demonstrated in chronic neuropathic pain conditions.
  THC-containing products (comparable THC-to-CBD ratio and synthetic high-THC) show
  the most consistent evidence for pain reduction, though with increased risk of sedation
  and dizziness. CBD offers a safer starting point with minimal adverse effects. Clinical
  guidance suggests CBD doses of 5-10mg twice daily increasing to 40-50mg daily, and
  THC doses starting at 0.5-3mg (initially at night) increasing to 30-40mg daily.
  Some patients may substitute cannabis for opioid medications, potentially improving
  risk-benefit profiles.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: Pain type
  direction: strengthens
  strength: moderate
  description: Effects primarily demonstrated in chronic neuropathic pain; studies
    of other pain conditions were lacking
- name: THC-to-CBD ratio
  direction: strengthens
  strength: moderate
  description: Comparable THC-to-CBD ratio products (1:1) and synthetic high-THC products
    showed associations with pain improvement
- name: Route of administration
  direction: strengthens
  strength: weak
  description: Different routes (tinctures, edibles, vaporized) have different onset
    times and duration; tinctures 15-45 min onset for breakthrough pain, edibles 6-8
    hours for extended relief
- name: Treatment duration
  direction: weakens
  strength: moderate
  description: Studies were of short duration (1-6 months); long-term effectiveness
    unclear
